Filtros de búsqueda

Lista de obras de

(18)F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide.

artículo científico publicado en 2015

18F-FDG PET/CT findings and circulating tumor cell counts in the monitoring of systemic therapies for bone metastases from breast cancer

artículo científico publicado en 2010

68Ga-PSMA PET/CT in patients with recurrent prostate cancer after radical treatment: prospective results in 314 patients

artículo científico publicado en 2018

<sup>68</sup>Ga-PSMA-11 PET/CT-Guided Stereotactic Body Radiation Therapy Retreatment in Prostate Cancer Patients with PSA Failure after Salvage Radiotherapy

scientific article published on 25 November 2020

A Phase II Study of Everolimus Plus Oral Prednisone in Patients with Metastatic Renal Cell Cancer

artículo científico publicado en 2017

A comprehensive review of the role of immune checkpoint inhibitors in elderly patients affected by renal cell carcinoma

artículo científico publicado en 2020

A long-term prospective population pharmacokinetic study on imatinib plasma concentrations in GIST patients

artículo científico publicado en 2012

A phase II study of a dose-density regimen with fluorouracil, epirubicin, and cyclophosphamide on days 1 and 4 every 14 days with filgrastim support followed by weekly paclitaxel in women with primary breast cancer.

artículo científico publicado en 2015

AR copy number and AR signaling-directed therapies in castration-resistant prostate cancer.

artículo científico publicado en 2017

Activity and safety of metronomic cyclophosphamide in the modern era of metastatic castration-resistant prostate cancer

scientific article published on 19 March 2019

Activity of Platinum-Based Chemotherapy in Patients With Advanced Prostate Cancer With and Without DNA Repair Gene Aberrations

artículo científico publicado en 2020

Activity of new agents (NAs) as third-line treatment in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) after a long-term disease control (LTDC) with abiraterone acetate (AA) or enzalutamide (ENZ) post docetaxel (DOC): Prelimin

Activity of new agents (NAs) as third-line treatment in metastatic castration-resistant prostate cancer (mCRPC) patients (pts) showing a primary resistance (PRes) to NAs-based second line therapy after docetaxel (DOC): Preliminary results from a mult

Adherence to abiraterone or enzalutamide in elderly metastatic castration-resistant prostate cancer

scientific article published on 20 January 2020

Adjuvant Carboplatin Treatment in 115 Patients With Stage I Seminoma: Retrospective Multicenter Survey.

artículo científico publicado en 2015

Adjuvant high-dose chemotherapy with autologous hematopoietic stem cell support for high-risk primary breast cancer: results from the Italian national registry.

artículo científico publicado en 2013

An 1H NMR study of the cytarabine degradation in clinical conditions to avoid drug waste, decrease therapy costs and improve patient compliance in acute leukemia

artículo científico publicado en 2020

An Italian, multicenter, real-world, retrospective study of first-line pazopanib in unselected metastatic renal-cell carcinoma patients: the 'Pamerit' study

artículo científico publicado en 2020

Androgen receptor signaling pathways as a target for breast cancer treatment

artículo científico publicado en 2016

Anticancer drug delivery with nanoparticles

artículo científico publicado en 2006

Are metastatic testicular tumors curable with high-dose chemotherapy and stem-cell rescue?

artículo científico publicado en 2008

Association Between Early PSA Increase and Clinical Outcome in Patients Treated with Enzalutamide for Metastatic Castration Resistant Prostate Cancer

artículo científico publicado en 2016

Association among metabolic syndrome, inflammation, and survival in prostate cancer

scientific article published on 02 March 2018

Association between circulating tumor cells and peripheral blood monocytes in metastatic breast cancer

artículo científico publicado en 2019

Association of Systemic Inflammation Index and Body Mass Index with Survival in Patients with Renal Cell Cancer Treated with Nivolumab

artículo científico publicado en 2019

Association of clinical progression at initiation of a life-extending therapy (LET) in metastatic castration-resistant prostate cancer (mCRPC) with poor prognosis: Results of the CATS database

Atezolizumab plus Bevacizumab Versus Sunitinib for Patients with Untreated Metastatic Renal Cell Carcinoma and Sarcomatoid Features: A Prespecified Subgroup Analysis of the IMmotion151 Clinical Trial

artículo científico publicado en 2020

Atezolizumab plus bevacizumab versus sunitinib in patients with previously untreated metastatic renal cell carcinoma (IMmotion151): a multicentre, open-label, phase 3, randomised controlled trial

scientific article published on 09 May 2019

Atezolizumab versus chemotherapy in patients with platinum-treated locally advanced or metastatic urothelial carcinoma (IMvigor211): a multicentre, open-label, phase 3 randomised controlled trial

artículo científico publicado en 2017

Atezolizumab with or without chemotherapy in metastatic urothelial cancer (IMvigor130): a multicentre, randomised, placebo-controlled phase 3 trial

artículo científico publicado en 2020

Autophagic Gene Polymorphisms in Liquid Biopsies and Outcome of Patients with Metastatic Clear Cell Renal Cell Carcinoma

Axitinib after Sunitinib in Metastatic Renal Cancer: Preliminary Results from Italian "Real-World" SAX Study.

artículo científico publicado en 2016

Bevacizumab As Maintenance Treatment in Patients With Ovarian Cancer: Wait for BRCA Testing

artículo científico publicado en 2019

Brain Metastases in Patients With Germ Cell Tumors: Prognostic Factors and Treatment Options--An Analysis From the Global Germ Cell Cancer Group

artículo científico publicado en 2015

Brain metastases in patients with EOC: Clinico-pathological and prognostic factors. A multicentric retrospective analysis from the MITO group (MITO 19).

artículo científico publicado en 2016

CAR-T cell therapy: a potential new strategy against prostate cancer

scientific article published on 16 October 2019

CYP17A1 polymorphisms and clinical outcome of castration-resistant prostate cancer patients treated with abiraterone.

artículo científico publicado en 2016

Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis

artículo científico publicado en 2020

Caregiver Emotional Burden in Testicular Cancer Patients: From Patient to Caregiver Support.

artículo científico publicado en 2019

Cell-free DNA as a diagnostic marker for cancer: current insights

artículo científico publicado en 2016

Characterization of metastatic breast cancer patients with nondetectable circulating tumor cells ⬇️

artículo científico publicado el 28 de noviembre de 2010

Chromogranin A is a potential prognostic marker in prostate cancer patients treated with enzalutamide

artículo científico publicado en 2014

Chromogranin A predicts outcome in prostate cancer patients treated with abiraterone

artículo científico publicado en 2014

Circulating AR copy number and outcome to enzalutamide in docetaxel-treated metastatic castration-resistant prostate cancer.

artículo científico publicado en 2016

Circulating tumor cells (CTCs) are associated with abnormalities in peripheral blood dendritic cells in patients with inflammatory breast cancer

artículo científico publicado en 2016

Circulating tumor cells and [18F]fluorodeoxyglucose positron emission tomography/computed tomography for outcome prediction in metastatic breast cancer.

artículo científico publicado en 2009

Circulating tumor cells as early predictors of metastatic spread in breast cancer patients with limited metastatic dissemination

artículo científico publicado en 2014

Circulating tumor cells as prognostic and predictive markers in metastatic breast cancer patients receiving first-line systemic treatment

artículo científico publicado en 2011

Circulating tumor cells in newly diagnosed inflammatory breast cancer

artículo científico publicado en 2015

Clinical Impact of Pancreatic Metastases from Renal Cell Carcinoma: A Multicenter Retrospective Analysis

artículo científico publicado en 2016

Clinical Outcomes of Castration-resistant Prostate Cancer Treatments Administered as Third or Fourth Line Following Failure of Docetaxel and Other Second-line Treatment: Results of an Italian Multicentre Study.

artículo científico publicado en 2014

Clinical outcome of patients who reduced sunitinib or pazopanib during first-line treatment for advanced kidney cancer.

artículo científico publicado en 2017

Clinical outcomes in a contemporary series of "young" patients with castration-resistant prostate cancer who were 60 years and younger

artículo científico publicado en 2015

Clinical outcomes in octogenarians treated with docetaxel as first-line chemotherapy for castration-resistant prostate cancer

artículo científico publicado en 2016

Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database

scientific article published on 29 November 2019

Combined Oral Fentanyl Citrate and Midazolam as Premedication for Bone Marrow Aspiration and Biopsy in Patients with Hematological Malignancies: A Randomized, Controlled and Patient-Blinded Clinical Trial

artículo científico publicado en 2020

Conditional survival of patients treated with first-line chemotherapy for metastatic urothelial cancer

scientific article published on 24 October 2014

Consider Quality of Life to Improve Quality of Cancer Guidelines

artículo científico publicado en 2017

Conventional-dose versus high-dose chemotherapy as first salvage treatment in male patients with metastatic germ cell tumors: evidence from a large international database

artículo científico publicado en 2011

Correction to: Cabozantinib After a Previous Immune Checkpoint Inhibitor in Metastatic Renal Cell Carcinoma: A Retrospective Multi-Institutional Analysis

artículo científico publicado en 2020

Correlation of Stomatitis and Cutaneous Toxicity With Clinical Outcome in Patients With Metastatic Renal-Cell Carcinoma Treated With Everolimus.

artículo científico publicado en 2016

Corrigendum to "Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration resistant prostate cancer: The CATS international database" [Eur J Canc 125, (January 2020) 153-163]

artículo científico publicado en 2020

Corrigendum to "Recommendations for surveillance and follow-up of men with testicular germ cell tumors: A multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica" [Crit. Rev. On

artículo científico publicado en 2020

Critical update and emerging trends in imatinib treatment for gastrointestinal stromal tumor.

artículo científico publicado en 2007

Differences in terms of progression-free survival (PFS) and overall survival (OS) in patients treated with first-line sorafenib, sunitinib, and pazopanib for late relapsing (>5 years) renal cell carcinoma

Dose Intensification in Hormone Receptor–Negative and/or Human Epidermal Growth Factor Receptor 2–Negative High-Risk Primary Breast Cancer ⬇️

artículo científico publicado el 27 de diciembre de 2011

Dose calculation and tolerability of adjuvant AUC 7 carboplatin in 100 patients with stage I seminoma

Dosimetry and safety of 177Lu PSMA-617 along with polyglutamate parotid gland protector: preliminary results in metastatic castration-resistant prostate cancer patients

scientific article published on 20 May 2020

Dovitinib versus sorafenib for third-line targeted treatment of patients with metastatic renal cell carcinoma: an open-label, randomised phase 3 trial.

artículo científico

Durvalumab alone and durvalumab plus tremelimumab versus chemotherapy in previously untreated patients with unresectable, locally advanced or metastatic urothelial carcinoma (DANUBE): a randomised, open-label, multicentre, phase 3 trial

scientific article published on 21 September 2020

Early Post-treatment Prostate-specific Antigen at 4 Weeks and Abiraterone and Enzalutamide Treatment for Advanced Prostate Cancer: An International Collaborative Analysis

artículo científico publicado en 2019

Early outcome prediction on 18F-fluorocholine PET/CT in metastatic castration-resistant prostate cancer patients treated with abiraterone

artículo científico publicado en 2014

Early use of abiraterone and radium-223 in metastatic prostate cancer

Editorial: Testicular Cancer: New Insights on the Origin, Genetics, Treatment, Fertility, General Health, Quality of Life and Sexual Function

artículo científico publicado en 2020

Effect of Baseline Characteristics on Cabazitaxel Treatment Duration in Patients with Metastatic Castration-Resistant Prostate Cancer: A Post Hoc Analysis of the Compassionate Use/Expanded Access Programs and CAPRISTANA Registry

scientific article published on 17 April 2020

Effect of Enzalutamide plus Androgen Deprivation Therapy on Health-related Quality of Life in Patients with Metastatic Hormone-sensitive Prostate Cancer: An Analysis of the ARCHES Randomised, Placebo-controlled, Phase 3 Study

artículo científico publicado en 2020

Effect of Weekly Paclitaxel With or Without Bevacizumab on Progression-Free Rate Among Patients With Relapsed Ovarian Sex Cord-Stromal Tumors: The ALIENOR/ENGOT-ov7 Randomized Clinical Trial

scientific article published on 08 October 2020

Effect of angiosonography to monitor response during imatinib treatment in patients with metastatic gastrointestinal stromal tumors.

artículo científico publicado en 2005

Efficacy of BGJ398, a Fibroblast Growth Factor Receptor 1–3 Inhibitor, in Patients with Previously Treated Advanced Urothelial Carcinoma with FGFR3 Alterations

artículo científico publicado en 2018

Enzalutamide after chemotherapy in advanced castration-resistant prostate cancer: the Italian Named Patient Program

article

Enzalutamide and Survival in Nonmetastatic, Castration-Resistant Prostate Cancer

artículo científico publicado en 2020

Enzalutamide for the treatment of nonmetastatic castration-resistant prostate cancer

artículo científico publicado en 2020

Erratum to 'Clinical progression is associated with poor prognosis whatever the treatment line in metastatic castration-resistant prostate cancer: The CATS international database' [European Journal of Cancer, Volume 125 (January 2020) Pages 153-163]

artículo científico publicado en 2020

Erratum to: 18F-Fluorocholine PET/CT for early response assessment in patients with metastatic castration-resistant prostate cancer treated with enzalutamide

artículo científico publicado en 2015

Expectations of survivors, caregivers and healthcare providers for testicular cancer survivorship and quality of life.

artículo científico publicado en 2011

Feasibility of radiotherapy after high-dose dense chemotherapy with epirubicin, preceded by dexrazoxane, and paclitaxel for patients with high-risk Stage II-III breast cancer

artículo científico publicado en 2006

First-Line PAzopanib in NOn-clear-cell Renal cArcinoMA: The Italian Retrospective Multicenter PANORAMA Study.

artículo científico publicado en 2016

GSTP1 Methylation and Protein Expression in Prostate Cancer: Diagnostic Implications

artículo científico publicado en 2016

Ga-PSMA-PET: added value and future applications in comparison to the current use of choline-PET and mpMRI in the workup of prostate cancer

scientific article published on 16 August 2018

Genome-wide plasma DNA methylation features of metastatic prostate cancer

artículo científico publicado en 2020

Germ cell tumors overexpress the candidate therapeutic target cyclin B1 independently of p53 function.

artículo científico publicado en 2015

Germ cell tumours of the testis

artículo científico publicado en 2005

Germ-cell tumors

artículo científico publicado en 2007

Hepatic metastases of hemangiopericytoma: contrast-enhanced MRI, contrast-enhanced ultrasonography and angiography findings

artículo científico publicado en 2006

High Neutrophil-to-lymphocyte Ratio Persistent During First-line Chemotherapy Predicts Poor Clinical Outcome in Patients with Advanced Urothelial Cancer

artículo científico publicado en 2014

High dose chemotherapy in germ cell tumors

artículo científico publicado en 2005

High-Dose Chemotherapy and Autologous Hematopoietic Stem Cell Transplantation as Adjuvant Treatment in High-Risk Breast Cancer: Data from the European Group for Blood and Marrow Transplantation Registry

artículo científico publicado en 2015

High-Dose Chemotherapy for Adult-Type Ovarian Granulosa Cell Tumors: A Retrospective Study of the European Society for Blood and Marrow Transplantation

artículo científico publicado en 2017

High-dose chemotherapy in a patient with coronavirus disease (COVID-19)

artículo científico publicado en 2020

High-dose chemotherapy in adult patients with germ cell tumors

artículo científico publicado en 2003

Human chorionic gonadotropin-positive seminoma patients: A registry compiled by the global germ cell tumor collaborative group (G3)

scientific article published on 29 April 2020

Hydroxychloroquine as Prophylaxis for COVID-19: A Review

artículo científico publicado en 2020

Hyperphosphatemia Secondary to the Selective Fibroblast Growth Factor Receptor 1-3 Inhibitor Infigratinib (BGJ398) Is Associated with Antitumor Efficacy in Fibroblast Growth Factor Receptor 3-altered Advanced/Metastatic Urothelial Carcinoma

artículo científico publicado en 2020

IGG practice guidelines on germ cell tumor in adult male patients

scientific article published on 01 January 2008

INfluenza Vaccine Indication During therapy with Immune checkpoint inhibitors: a transversal challenge. The INVIDIa study

Imatinib and gastrointestinal stromal tumors: Where do we go from here?

artículo científico publicado en 2005

Immune Modulation in Prostate Cancer Patients Treated with Androgen Receptor (AR)-Targeted Therapy

artículo científico publicado en 2020

Immune System and DNA Repair Defects in Ovarian Cancer: Implications for Locoregional Approaches

artículo científico publicado en 2019

Immune-Related Concepts in Biology and Treatment of Germ-Cell Tumors.

artículo científico publicado en 2018

Immunotherapy for Prostate Cancer: Where We Are Headed

artículo científico publicado en 2017

Impact of influenza syndrome and flu vaccine on survival of cancer patients during immunotherapy in the INVIDIa study

artículo científico publicado en 2020

Impact of timing of adjuvant chemotherapy following radical cystectomy for bladder cancer on patient survival

scientific article published on 10 July 2020

Impact of visceral metastases on outcome to abiraterone after docetaxel in castration-resistant prostate cancer patients.

artículo científico publicado en 2015

Infigratinib in upper tract urothelial carcinoma versus urothelial carcinoma of the bladder and its association with comprehensive genomic profiling and/or cell-free DNA results

scientific article published on 24 March 2020

Inflammatory Biomarkers as Predictors of Response to Immunotherapy in Urological Tumors

artículo científico publicado en 2019

Inflammatory Indexes as Prognostic and Predictive Factors in Ovarian Cancer Treated with Chemotherapy Alone or Together with Bevacizumab. A Multicenter, Retrospective Analysis by the MITO Group (MITO 24)

Inflammatory indexes as predictive factors for platinum sensitivity and as prognostic factors in recurrent epithelial ovarian cancer patients: a MITO24 retrospective study

artículo científico publicado en 2020

Inflammatory indexes as predictors of prognosis and bevacizumab efficacy in patients with metastatic colorectal cancer

artículo científico publicado en 2016

International evaluation of the psychometrics of health-related quality of life questionnaires for use among long-term survivors of testicular and prostate cancer ⬇️

artículo científico publicado en 2017

Is It Possible to Improve Prognostic Classification in Patients Affected by Metastatic Renal Cell Carcinoma With an Intermediate or Poor Prognosis?

scientific article published on 07 May 2018

Is high-dose chemotherapy after primary chemotherapy a therapeutic option for patients with primary mediastinal nonseminomatous germ cell tumor?

artículo científico publicado en 2006

Just say cancer

scientific article published on 01 July 2008

KIT mutations and imatinib dose effects in patients with gastrointestinal stromal tumors

artículo científico publicado en 2007

Ki67 and PR in Patients Treated with CDK4/6 Inhibitors: A Real-World Experience

artículo científico publicado en 2020

Lack of Effectiveness of Postchemotherapy Lymphadenectomy in Bladder Cancer Patients with Clinical Evidence of Metastatic Pelvic or Retroperitoneal Lymph Nodes Only: A Propensity Score-based Analysis

artículo científico publicado en 2017

Lenvatinib in the management of metastatic renal cell carcinoma: a promising combination therapy?

artículo científico publicado en 2018

Long-term Response to First-line Pazopanib Therapy in mRCC Patients: A Multicenter Italian Experience

scientific article published on 01 August 2018

Long-term clinical impact of PSA surge in castration-resistant prostate cancer patients treated with abiraterone.

artículo científico publicado en 2017

Long-term outcome of salvage high-dose chemotherapy in patients with germ cell tumor with poor prognostic features.

artículo científico publicado en 2009

Lymphopenia and clinical outcome of elderly patients treated with sunitinib for metastatic renal cell cancer.

artículo científico publicado en 2014

Management of germ cell tumors during the outbreak of the novel coronavirus disease-19 pandemic: a survey of international expertise centers

artículo científico publicado en 2020

Mesenchymal stem cells expressing GD2 and CD271 correlate with breast cancer-initiating cells in bone marrow.

artículo científico publicado en 2011

Metabolic syndrome in castration-resistant prostate cancer patients treated with abiraterone.

artículo científico publicado en 2015

Methylation pattern analysis in prostate cancer tissue: identification of biomarkers using an MS-MLPA approach.

artículo científico publicado en 2016

Molecular mechanisms of resistance in testicular germ cell tumors - Clinical implications

artículo científico publicado en 2018

Moving beyond PARP Inhibition: Current State and Future Perspectives in Breast Cancer ⬇️

journal article from 'International Journal of Molecular Sciences' published in 2021

Negative prognostic factors and resulting clinical outcome in patients with metastatic renal cell carcinoma included in the Italian nivolumab-expanded access program

article

Neoadjuvant vs. Adjuvant Chemotherapy in Muscle Invasive Bladder Cancer (MIBC): Analysis From the RISC Database

Neuroendocrine differentiation in prostate cancer: current and emerging therapy strategies

artículo científico publicado en 2014

Neutrophil-to-lymphocyte ratio and lactate dehydrogenase as biomarkers for urothelial cancer treated with immunotherapy

artículo científico publicado en 2020

Nomogram-based Prediction of Overall Survival in Patients with Metastatic Urothelial Carcinoma Receiving First-line Platinum-based Chemotherapy: Retrospective International Study of Invasive/Advanced Cancer of the Urothelium (RISC).

artículo científico publicado en 2016

Outcome of Patients with Renal Cell Carcinoma and Multiple Glandular Metastases Treated with Targeted Agents

artículo científico publicado en 2017

Outcome of oligoprogressing metastatic renal cell carcinoma patients treated with locoregional therapy: a multicenter retrospective analysis

artículo científico publicado en 2017

Outcomes of metastatic castration-resistant prostate cancer (mCRPC) patients (pts) treated with different new agents (NAs) sequence in post-docetaxel (DOC) setting: Final analysis from a multicenter Italian study

article

Ovarian Sertoli-Leydig cell tumor, endometrioid-like yolk sac tumor, and Y-chromosomal material.

artículo científico publicado en 2003

Oxaliplatin plus leucovorin and 5-fluorouracil (FOLFOX-4) as a salvage chemotherapy in heavily-pretreated platinum-resistant ovarian cancer

artículo científico publicado en 2018

PSA flare with abiraterone in patients with metastatic castration-resistant prostate cancer

artículo científico publicado en 2014

PSMA expression: a potential ally for the pathologist in prostate cancer diagnosis.

artículo científico publicado en 2018

Pazopanib versus sunitinib in metastatic renal-cell carcinoma

artículo científico publicado en 2013

Pegylated liposomal doxorubicin re-challenge in patients with ovarian cancer relapse: a multicenter retrospective study

artículo científico publicado en 2019

Persistent Neutrophil to Lymphocyte Ratio >3 during Treatment with Enzalutamide and Clinical Outcome in Patients with Castration-Resistant Prostate Cancer.

artículo científico publicado en 2016

Perspectives on mTOR inhibitors for castration-refractory prostate cancer.

artículo científico publicado en 2012

Pharmacokinetics, pharmacodynamics and clinical efficacy of nivolumab in the treatment of metastatic renal cell carcinoma.

artículo científico publicado en 2016

Phase II study of oxaliplatin and gemcitabine salvage chemotherapy in patients with cisplatin-refractory nonseminomatous germ cell tumor

artículo científico publicado en 2006

Phase III Study of Cabozantinib in Previously Treated Metastatic Castration-Resistant Prostate Cancer: COMET-1.

artículo científico publicado en 2016

Plasma AR Copy Number Changes and Outcome to Abiraterone and Enzalutamide

artículo científico publicado en 2020

Plasma AR and abiraterone-resistant prostate cancer.

artículo científico publicado en 2015

Plasma AR status and cabazitaxel in heavily treated metastatic castration-resistant prostate cancer

artículo científico publicado en 2019

Plasma Androgen Receptor Copy Number Status at Emergence of Metastatic Castration-Resistant Prostate Cancer: A Pooled Multicohort Analysis

scientific article published on 24 September 2019

Plasma Androgen Receptor and Docetaxel for Metastatic Castration-resistant Prostate Cancer

artículo científico publicado en 2018

Plasma Androgen Receptor in Prostate Cancer

artículo científico publicado en 2019

Plasma androgen receptor and serum chromogranin A in advanced prostate cancer

artículo científico publicado en 2018

Plasma tumour DNA as an early indicator of treatment response in metastatic castration-resistant prostate cancer

artículo científico publicado en 2020

Polychemotherapy in overseventy breast cancer patients

artículo científico publicado en 2002

Potential Application of Chimeric Antigen Receptor (CAR)-T Cell Therapy in Renal Cell Tumors

artículo científico publicado en 2020

Predictors of long-term response to abiraterone in patients with metastastic castration-resistant prostate cancer: a retrospective cohort study.

artículo científico publicado en 2016

Prevention and therapy of neutropenia in elderly patients

artículo científico publicado en 2003

Primary Results from SAUL, a Multinational Single-arm Safety Study of Atezolizumab Therapy for Locally Advanced or Metastatic Urothelial or Nonurothelial Carcinoma of the Urinary Tract

scientific article published on 23 March 2019

Primary resistance to abiraterone acetate (AA) after docetaxel treatment in metastatic castration-resistant prostate cancer (mCRPC): A multicenter retrospective analysis

Prognostic Factors in Patients With Metastatic Germ Cell Tumors Who Experienced Treatment Failure With Cisplatin-Based First-Line Chemotherapy ⬇️

artículo científico publicado el 18 de octubre de 2010

Prognostic Role of Systemic Inflammatory Indexes in Germ Cell Tumors Treated With High-Dose Chemotherapy

scientific article published on 14 August 2020

Prognostic significance of host immune status in patients with late relapsing renal cell carcinoma treated with targeted therapy

artículo científico publicado en 2015

Prognostic value of 18F-choline PET/CT metabolic parameters in patients with metastatic castration-resistant prostate cancer treated with abiraterone or enzalutamide.

artículo científico publicado en 2017

Prognostic value of neutrophil-to-lymphocyte ratio (NLR) in metastatic castration-resistant prostate cancer (mCRPC) pts receiving a new agent (NA)- based third line treatment: Final results from a multicenter Italian study

article

Prolonged exposure to (R)-bicalutamide generates a LNCaP subclone with alteration of mitochondrial genome

artículo científico publicado en 2013

Psychosocial Issues in Long-Term Survivors of Testicular Cancer

Questioning the Value of Fluorodeoxyglucose Positron Emission Tomography for Residual Lesions After Chemotherapy for Metastatic Seminoma: Results of an International Global Germ Cell Cancer Group Registry

artículo científico publicado en 2018

Radical cystectomy or bladder preservation with radiochemotherapy in elderly patients with muscle-invasive bladder cancer: Retrospective International Study of Cancers of the Urothelial Tract (RISC) Investigators

artículo científico publicado en 2017

Randomized Phase II Study Evaluating Akt Blockade with Ipatasertib, in Combination with Abiraterone, in Patients with Metastatic Prostate Cancer with and without PTEN Loss

artículo científico publicado en 2018

Randomized, controlled, double-blind, cross-over trial assessing treatment preference for pazopanib versus sunitinib in patients with metastatic renal cell carcinoma: PISCES Study

artículo científico publicado en 2014

Re: Marzia Del Re, Elisa Biasco, Stefania Crucitta, et al. The Detection of Androgen Receptor Splice Variant 7 in Plasma-derived Exosomal RNA Strongly Predicts Resistance to Hormonal Therapy in Metastatic Prostate Cancer Patients. Eur Urol 2017;71:6

artículo científico publicado en 2017

Re: Niven Mehra, David Dolling, Semini Sumanasuriya, et al. Plasma Cell-free DNA Concentration and Outcomes from Taxane Therapy in Metastatic Castration-resistant Prostate Cancer from Two Phase III Trials (FIRSTANA and PROSELICA). Eur Urol 2018;74:2

artículo científico publicado en 2018

Re: Pasquale Rescigno, David Lorente, Diletta Bianchini, et al. Prostate-specific Antigen Decline After 4 Weeks of Treatment with Abiraterone Acetate and Overall Survival in Patients with Metastatic Castration-resistant Prostate Cancer. Eur Urol 201

artículo científico publicado en 2016

Real-World Data on Cabozantinib in Previously Treated Patients with Metastatic Renal Cell Carcinoma: Focus on Sequences and Prognostic Factors

scientific article published on 30 December 2019

Real-life clinical practice results with vinflunine in patients with relapsed platinum-treated metastatic urothelial carcinoma: an Italian multicenter study (MOVIE-GOIRC 01-2014).

artículo científico publicado en 2017

Real-world efficacy and safety of nivolumab in previously-treated metastatic renal cell carcinoma, and association between immune-related adverse events and survival: the Italian expanded access program

article

Reclassification of good-risk seminoma: prognostic factors, novel biomarkers and implications for clinical management

artículo científico publicado en 2019

Recommendations for surveillance and follow-up of men with testicular germ cell tumors: a multidisciplinary consensus conference by the Italian Germ cell cancer Group and the Associazione Italiana di Oncologia Medica

scientific article published on 20 March 2019

Recruiting long-term survivors of European Organisation for Research and Treatment of Cancer phase III clinical trials into quality of life studies: challenges and opportunities

artículo científico publicado en 2014

Reduction of 68Ga-PSMA renal uptake with mannitol infusion: preliminary results

artículo científico publicado en 2017

Relationship between lymphocytopenia and circulating tumor cells as prognostic factors for overall survival in metastatic breast cancer

artículo científico publicado en 2012

Reply to the letter to the editor 'Androgen deprivation therapy and risk of rheumatoid arthritis in patients with localized prostate cancer' by Yang et al

artículo científico publicado en 2018

Risk of gastrointestinal events with sorafenib, sunitinib and pazopanib in patients with solid tumors: a systematic review and meta-analysis of clinical trials

artículo científico publicado en 2014

Risk of ipsilateral lung cancer after postmastectomy radiotherapy and smoking: does the possible triumph over the actual?

artículo científico publicado en 2008

Risk of recurrence and conditional survival in complete responders treated with TKIs plus or less locoregional therapies for metastatic renal cell carcinoma

artículo científico publicado en 2016

Robot-assisted Versus Open Radical Cystectomy in Patients Receiving Perioperative Chemotherapy for Muscle-invasive Bladder Cancer: The Oncologist's Perspective from a Multicentre Study.

artículo científico publicado en 2017

Role and relevance of quality indicators in the selection of first-line treatment of patients with metastatic renal cell carcinoma: a position paper of the MeetURO Group

artículo científico publicado en 2019

Role of DNA repair machinery and p53 in the testicular germ cell cancer: a review

artículo científico publicado en 2016

Safety and Clinical Outcomes of Abiraterone Acetate After Docetaxel in Octogenarians With Metastatic Castration-Resistant Prostate Cancer: Results of the Italian Compassionate Use Named Patient Programme

artículo científico publicado en 2015

Safety and Efficacy of Cabozantinib for Metastatic Nonclear Renal Cell Carcinoma: Real-world Data From an Italian Managed Access Program

artículo científico publicado en 2019

Safety and Efficacy of Cabozantinib in Metastatic Renal-Cell Carcinoma: Real-World Data From an Italian Managed Access Program

article

Safety and clinical outcome of a cohort of patients (pts) with castration resistant prostate cancer (CRPC) treated with abiraterone acetate (AA) in a named patient program (NPP): Updated results of a retrospective study from an Italian cooperative gr

article

Safety and clinical outcomes of patients treated with abiraterone acetate after docetaxel: results of the Italian Named Patient Programme

article

Safety and efficacy of nivolumab for metastatic renal cell carcinoma (mRCC): Real world data from an Italian expanded access program (EAP)

article

Safety and efficacy of nivolumab for metastatic renal cell carcinoma: real-world results from an expanded access programme

artículo científico publicado en 2018

Salvage high-dose chemotherapy in patients with germ cell tumors

artículo científico publicado en 2002

Salvage treatment of relapsed or refractory germ-cell tumours

artículo científico publicado en 2013

Second line therapy with axitinib after only prior sunitinib in metastatic renal cell cancer: Italian multicenter real world SAX study final results

artículo científico publicado en 2019

Sequencing of Taxanes and New Androgen-targeted Therapies in Metastatic Castration-resistant Prostate Cancer: Results of the International Multicentre Retrospective CATS Database

artículo científico publicado en 2018

Sequential administration of new agents (NAs) after docetaxel (DOC) in metastatic castration-resistant prostate cancer (mCRPC) patients (pts): Impact of disease control (DC) duration in second line on the subsequent line outcomes

Severe Complications in Testicular Germ Cell Tumors: The Choriocarcinoma Syndrome

Sorafenib as first- or second-line therapy in patients with metastatic renal cell carcinoma in a community setting

artículo científico publicado en 2014

Standard vs adapted sunitinib regimen in elderly patients with metastatic renal cell cancer: results from a large retrospective analysis.

artículo científico publicado en 2013

State of the art about influenza vaccination for advanced cancer patients receiving immune checkpoint inhibitors: When common sense is not enough

artículo científico publicado en 2019

Sunitinib, pazopanib or sorafenib for the treatment of patients with late relapsing metastatic renal cell carcinoma

artículo científico publicado en 2014

Surgical resection does not improve survival in patients with renal metastases to the pancreas in the era of tyrosine kinase inhibitors

artículo científico publicado en 2014

Survival Outcomes From a Cumulative Analysis of Worldwide Observational Studies on Sequential Use of New Agents in Metastatic Castration-Resistant Prostate Cancer

scientific article published on 27 September 2019

Symptomatic COVID-19 in advanced-cancer patients treated with immune-checkpoint inhibitors: prospective analysis from a multicentre observational trial by FICOG

artículo científico publicado en 2020

Systemic Immune-Inflammation Index Predicts the Clinical Outcome in Patients with mCRPC Treated with Abiraterone.

artículo científico publicado en 2016

Systemic immune-inflammation index in germ-cell tumours

artículo científico publicado en 2018

Systemic immune-inflammation index predicts the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib

artículo científico publicado en 2016

Systemic immune-inflammation index to predict the clinical outcome in patients with metastatic renal cell cancer treated with sunitinib

TARIBO trial: targeted therapy with or without nephrectomy in metastatic renal cell carcinoma: liquid biopsy for biomarkers discovery.

artículo científico publicado en 2017

Targeted therapies for advanced bladder cancer: new strategies with FGFR inhibitors

artículo científico publicado en 2019

Taxane-related nail toxicity.

artículo científico publicado en 2015

Testosterone levels and androgen receptor copy number variations in castration-resistant prostate cancer treated with abiraterone or enzalutamide

scientific article published on 01 August 2019

The Impact of Cisplatin- or Non-Cisplatin-Containing Chemotherapy on Long-Term and Conditional Survival of Patients with Advanced Urinary Tract Cancer

artículo científico publicado en 2019

The Interplay between Inflammation, Anti-Angiogenic Agents, and Immune Checkpoint Inhibitors: Perspectives for Renal Cell Cancer Treatment

scientific article published on 04 December 2019

The Khorana Score in Predicting Venous Thromboembolism for Patients With Metastatic Urothelial Carcinoma and Variant Histology Treated With Chemotherapy

artículo científico publicado en 2016

The MITO CERV-2 trial: A randomized phase II study of cetuximab plus carboplatin and paclitaxel, in advanced or recurrent cervical cancer

scientific article published on 09 April 2019

The cyclin-dependent kinases pathway as a target for prostate cancer treatment: rationale and future perspectives

artículo científico publicado en 2020

The effect of a treatment delay on outcome in metastatic renal cell carcinoma

artículo científico publicado en 2019

The emerging role of anti-angiogenic therapy in ovarian cancer (review).

artículo científico publicado en 2014

The outcome to axitinib or everolimus after sunitinib in metastatic renal cell carcinoma

artículo científico publicado en 2018

The potential use of urine cell free DNA as a marker for cancer.

artículo científico publicado en 2016

The prognostic value of pain in castration-sensitive prostate cancer

artículo científico publicado en 2020

The status of high-dose chemotherapy with hematopoietic stem cell transplantation in germ cell tumor patients.

artículo científico publicado en 2002

Therapeutic Challenges for Cisplatin-Resistant Ovarian Germ Cell Tumors

scientific article published on 17 October 2019

Treatment Outcome of metastatic lesions from renal cell carcinoma underGoing Extra-cranial stereotactic body radioTHERapy: The together retrospective study

artículo científico publicado en 2019

Treatment of Metastatic Urothelial Carcinoma After Previous Cisplatin-based Chemotherapy for Localized Disease: A Retrospective Comparison of Different Chemotherapy Regimens

scientific article published on 12 November 2020

Treatment-related fatigue with sorafenib, sunitinib and pazopanib in patients with advanced solid tumors: an up-to-date review and meta-analysis of clinical trials.

artículo científico

Tumorlets in Familial History of Bronchopulmonary Carcinoid

Urinary RNA-based biomarkers for prostate cancer detection.

artículo científico publicado en 2017

Urine Cell-Free DNA Integrity Analysis for Early Detection of Prostate Cancer Patients

artículo científico publicado en 2015

Urothelial Cancer: Inflammatory Mediators and Implications for Immunotherapy.

artículo científico publicado en 2016

Value of pharmacokinetic studies for patients with gastrointestinal stromal tumors

artículo científico publicado en 2013

Venous Thromboembolism Risk in Patients With Locoregional Urothelial Tract Tumors.

artículo científico publicado en 2017

Venous thromboembolism in metastatic urothelial carcinoma or variant histologies: incidence, associative factors, and effect on survival

scientific article published on 20 December 2016

Vitamin D Deficiency in Testicular Cancer Survivors: A Systematic Review ⬇️

artículo científico

Vitamin D status among long-term survivors of testicular cancer

artículo científico publicado en 2016

Vitiligo-like lesions in a patient treated with nivolumab for renal cell carcinoma

Weekly gemcitabine, paclitaxel, oxaliplatin combination chemotherapy in patients with Cisplatin-refractory germ cell tumor: preliminary experience

artículo científico publicado en 2004

[177Lu]-PSMA-617 for targeted prostate cancer treatment: a magic bullet?

scientific article published on 08 May 2018

[18F]Fluorodeoxyglucose positron emission tomography for outcome prediction of mammalian target of rapamycin inhibitor therapy

artículo científico publicado en 2010

[Influenza vaccination in advanced cancer patients undergoing immunotherapy with anti-PD-1/PD-L1 immune checkpoint inhibitors: what data do we have for the clinical recommendation?]

artículo científico publicado en 2018

Dominio Público Uruguay está sostenido por:

Acerca de Dominio Público Uruguay

Ayuda